Robitussin Honey CF Max Nighttime Adult Recalled for Microbial Contamination
Haleon US Holdings LLC is recalling Robitussin Honey CF Max Nighttime Adult cough medicine due to microbial contamination. The FDA Class I recall affects 21,900 bottles distributed nationwide.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: FDA Class I classification requires a minimum severity score of 4 per the rubric. No illnesses or deaths are reported in the source, preventing a Critical rating. Microbial contamination of drug products represents a serious health hazard warranting immediate recall.
Plain-English summary
Haleon US Holdings LLC is recalling Robitussin Honey CF Max Nighttime Adult (Acetaminophen 650 mg, Diphenhydramine HCl 25 mg), 8 fluid ounce bottles. The FDA has classified this as a Class I recall due to microbial contamination of the product.
The affected product includes bottles bearing lot numbers T08740 and T08742, with an expiration date of June 30, 2026. Approximately 21,900 bottles were distributed nationwide by GSK Consumer Healthcare, located in Warren, New Jersey.
Consumers who have this product should stop using it. Those with health concerns should contact a healthcare provider.
The recalled product
- Product
- Robitussin Honey CF Max Nighttime Adult (Acetaminophen 650 mg, Diphenhydramine HCl 25mg), 8 FL OZ (237 mL) bottle, Distributed by: GSK Consumer Healthcare, Warren, NJ 07059
- Manufacturer
- Haleon US Holdings LLC
- Category
- Drug — OTC Cough Medicine
- Hazard
- microbial-contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot#: T08740
- T08742
- Exp 06/30/2026
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27